Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats

Heart Rhythm

Volumn 8, Issue 2, 2011, Pages 278-285

  Kume, Osamu ^a   Takahashi, Naohiko ^b   Wakisaka, Osamu ^a   Nagano Torigoe, Yasuko ^b   Teshima, Yasushi ^b   Nakagawa, Mikiko ^b   Yufu, Kunio ^b   Hara, Masahide ^a   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Fibrosis; Inflammation; Monocyte chemoattractant protein 1; Peroxisome proliferator activated receptor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; ATRIAL FIBROSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT ATRIUM; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADMINISTRATION, ORAL; ANIMALS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROSIS; HEART ATRIA; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MATRIX METALLOPROTEINASE 9; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THIAZOLIDINEDIONES;

EID: 79251565539     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.10.029     Document Type: Article

References (33)

1. E. Benjamin, P. Wolf, R. D'Agostino, H. Silbershatz, W. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham heart study Circulation 98 1998 946 952
2. A. Go, E. Hylek, and K. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study JAMA 285 2001 2370 2375
3. B. Burstein, and S. Nattel Atrial structural remodeling as an antiarrhythmic target J Cardiovasc Pharmacol 52 2008 4 10
4. D. Corradi, S. Callegari, R. Maestri, S. Benussi, and O. Alfieri Structural remodeling in atrial fibrillation Nat Clin Pract Cardiovasc Med 5 2008 782 796
5. M. Smit, and I. Van Gelder Upstream therapy of atrial fibrillation Expert Rev Cardiovasc Ther 7 2009 763 778
6. O. Wakisaka, N. Takahashi, and T. Shinohara Hyperthermia treatment prevents angiotensin ii-mediated atrial fibrosis and fibrillation via induction of heat-shock protein 72 J Mol Cell Cardiol 43 2007 616 626
7. S. Nattel, B. Burstein, and D. Dobrev Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 1 2008 62 73
8. H. Kai, F. Kuwahara, K. Tokuda, and T. Imaizumi Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis Hypertens Res 28 2005 483 490
9. C. Zhang, S. Yasuno, and K. Kuwahara Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy Circ J 70 2006 335 341
10. O. Adam, G. Frost, and F. Custodis Role of rac1 GTPase activation in atrial fibrillation J Am Coll Cardiol 50 2007 359 367
11. A. Ceriello Thiazolidinediones as anti-inflammatory and anti-atherogenic agents Diabetes Metab Res Rev 24 2008 14 26
12. M. Nakamoto, Y. Ohya, and T. Shinzato Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension Hypertens Res 31 2008 353 361
13. M. Kato, R. Shibata, and K. Obata Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt J Hypertens 26 2008 1669 1676
14. N. Makino, T. Maeda, J. Oyama, Y. Higuchi, and K. Mimori Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats Am J Physiol Heart Circ Physiol 297 2009 H2188 H2195
15. M. Fukuda, T. Nakamura, and K. Kataoka Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice J Hypertens 28 2010 340 352
16. M. Shimano, Y. Tsuji, and Y. Inden Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure Heart Rhythm 5 2008 451 459
17. T. Ooie, N. Takahashi, and T. Saikawa Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart Circulation 104 2001 1837 1843
18. T. Shinohara, N. Takahashi, and T. Ooie Phosphatidylinositol 3-kinase-dependent activation of Akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart Diabetes 55 2006 1307 1315
19. Y. Taniguchi, T. Ooie, and N. Takahashi Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat Diabetes 55 2006 2371 2378
20. B. Burstein, E. Libby, A. Calderone, and S. Nattel Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences Circulation 117 2008 1630 1641
21. M. Wijffels, C. Kirchhof, R. Dorland, and M. Allessie Atrial fibrillation begets atrial fibrillation A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
22. P. Libby, P. Ridker, and G. Hansson Inflammation in atherosclerosis: from pathophysiology to practice J Am Coll Cardiol 54 2009 2129 2138
23. T. Yamashita, A. Sekiguchi, and Y. Iwasaki Recruitment of immune cells across atrial endocardium in human atrial fibrillation Circ J 74 2010 262 270
24. I. Charo, and M. Taubman Chemokines in the pathogenesis of vascular disease Circ Res 95 2004 858 866
25. T. Kasai, K. Miyauchi, and T. Yokoyama Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting Atherosclerosis 197 2008 612 619
26. Y. Xia, K. Lee, N. Li, D. Corbett, L. Mendoza, and N. Frangogiannis Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload Histochem Cell Biol 131 2009 471 481
27. J. Li, J. Solus, and Q. Chen Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
28. P. Snoek-van Beurden, and J. Von den Hoff Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors Biotechniques 38 2005 73 83
29. Y. Nakano, S. Niida, and K. Dote Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J Am Coll Cardiol 43 2004 818 825
30. S. Inoue, K. Egashira, and W. Ni Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice Circulation 106 2002 2700 2706
31. N. Marx, U. Schnbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1998 1097 1103
32. R. Unal, A. Yao-Borengasser, and V. Varma Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone J Clin Endocrinol Metab 95 2010 2993 3001
33. M. Asakawa, H. Takano, and T. Nagai Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246